236 related articles for article (PubMed ID: 12200361)
1. Graft-versus-leukemia effect after suicide-gene-mediated control of graft-versus-host disease.
Litvinova E; Maury S; Boyer O; Bruel S; Benard L; Boisserie G; Klatzmann D; Cohen JL
Blood; 2002 Sep; 100(6):2020-5. PubMed ID: 12200361
[TBL] [Abstract][Full Text] [Related]
2. Suicide gene therapy of graft-versus-host disease: immune reconstitution with transplanted mature T cells.
Cohen JL; Boyer O; Klatzmann D
Blood; 2001 Oct; 98(7):2071-6. PubMed ID: 11567992
[TBL] [Abstract][Full Text] [Related]
3. Control of graft-versus-host disease with maintenance of the graft-versus-leukemia effect in a murine allogeneic transplant model using retrovirally transduced murine suicidal lymphocytes.
Kornblau SM; Aycox PG; Stephens C; McCue LD; Champlin RE; Marini FC
Exp Hematol; 2007 May; 35(5):842-53. PubMed ID: 17577932
[TBL] [Abstract][Full Text] [Related]
4. Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytes.
Bondanza A; Valtolina V; Magnani Z; Ponzoni M; Fleischhauer K; Bonyhadi M; Traversari C; Sanvito F; Toma S; Radrizzani M; La Seta-Catamancio S; Ciceri F; Bordignon C; Bonini C
Blood; 2006 Mar; 107(5):1828-36. PubMed ID: 16293601
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of in vivo elimination of suicide gene-expressing T cells affects engraftment, graft-versus-host disease, and graft-versus-leukemia after allogeneic bone marrow transplantation.
Rettig MP; Ritchey JK; Prior JL; Haug JS; Piwnica-Worms D; DiPersio JF
J Immunol; 2004 Sep; 173(6):3620-30. PubMed ID: 15356106
[TBL] [Abstract][Full Text] [Related]
6. Effect of combined cytostatic cyclosporin A and cytolytic suicide gene therapy on the prevention of experimental graft-versus-host disease.
Maury S; Litvinova E; Boyer O; Benard L; Bruel S; Klatzmann D; Cohen JL
Gene Ther; 2002 Feb; 9(3):201-7. PubMed ID: 11859423
[TBL] [Abstract][Full Text] [Related]
7. Elimination of leukemia in the absence of lethal graft-versus-host disease after allogenic bone marrow transplantation.
Drobyski WR; Gendelman M; Vodanovic-Jankovic S; Gorski J
J Immunol; 2003 Mar; 170(6):3046-53. PubMed ID: 12626559
[TBL] [Abstract][Full Text] [Related]
8. Immunological defects after suicide gene therapy of experimental graft-versus-host disease.
Cohen JL; Lacroix-Desmazes S; Charlotte F; Lejeune L; Martin PJ; Klatzmann D; Boyer O
Hum Gene Ther; 1999 Nov; 10(16):2701-7. PubMed ID: 10566898
[TBL] [Abstract][Full Text] [Related]
9. Herpes simplex thymidine kinase gene-transduced donor lymphocyte infusions.
Burt RK; Drobyski WR; Seregina T; Traynor A; Oyama Y; Keever-Taylor C; Stefka J; Kuzel TM; Brush M; Rodriquez J; Burns W; Tennant L; Link C
Exp Hematol; 2003 Oct; 31(10):903-10. PubMed ID: 14550806
[TBL] [Abstract][Full Text] [Related]
10. Regulation of alloresponses after bone marrow transplantation using donor T cells expressing a thymidine kinase suicide gene.
Drobyski WR; Gendelman M
Leuk Lymphoma; 2002 Oct; 43(10):2011-6. PubMed ID: 12481900
[TBL] [Abstract][Full Text] [Related]
11. Thymidine kinase (TK) gene-transduced human lymphocytes can be highly purified, remain fully functional, and are killed efficiently with ganciclovir.
Munshi NC; Govindarajan R; Drake R; Ding LM; Iyer R; Saylors R; Kornbluth J; Marcus S; Chiang Y; Ennist D; Kwak L; Reynolds C; Tricot G; Barlogie B
Blood; 1997 Feb; 89(4):1334-40. PubMed ID: 9028956
[TBL] [Abstract][Full Text] [Related]
12. Selective T-cell subset ablation demonstrates a role for T1 and T2 cells in ongoing acute graft-versus-host disease: a model system for the reversal of disease.
Liu J; Anderson BE; Robert ME; McNiff JM; Emerson SG; Shlomchik WD; Shlomchik MJ
Blood; 2001 Dec; 98(12):3367-75. PubMed ID: 11719376
[TBL] [Abstract][Full Text] [Related]
13. Graft-versus-leukemia effect of HLA-haploidentical central-memory T-cells expanded with leukemic APCs and modified with a suicide gene.
Casucci M; Perna SK; Falcone L; Camisa B; Magnani Z; Bernardi M; Crotta A; Tresoldi C; Fleischhauer K; Ponzoni M; Gregori S; Caligaris Cappio F; Ciceri F; Bordignon C; Cignetti A; Bondanza A; Bonini C
Mol Ther; 2013 Feb; 21(2):466-75. PubMed ID: 23299798
[TBL] [Abstract][Full Text] [Related]
14. Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft.
Tiberghien P; Ferrand C; Lioure B; Milpied N; Angonin R; Deconinck E; Certoux JM; Robinet E; Saas P; Petracca B; Juttner C; Reynolds CW; Longo DL; Hervé P; Cahn JY
Blood; 2001 Jan; 97(1):63-72. PubMed ID: 11133743
[TBL] [Abstract][Full Text] [Related]
15. Ganciclovir-mediated elimination of HSV-Tk+ T cells and cure of graft-vs-host disease in an allogeneic bone marrow transplantation model in the rat.
Weijtens M; van Spronsen A; Hagenbeek A; de Weger R; Martens A
Exp Hematol; 2004 Oct; 32(10):962-9. PubMed ID: 15504552
[TBL] [Abstract][Full Text] [Related]
16. Protection from lethal murine graft-versus-host disease without compromise of alloengraftment using transgenic donor T cells expressing a thymidine kinase suicide gene.
Drobyski WR; Morse HC; Burns WH; Casper JT; Sandford G
Blood; 2001 Apr; 97(8):2506-13. PubMed ID: 11290616
[TBL] [Abstract][Full Text] [Related]
17. Suicide-gene-Transduced donor T-cells for controlled graft-versus-host disease and graft-versus-tumor.
Ciceri F; Bordignon C
Int J Hematol; 2002 Nov; 76(4):305-9. PubMed ID: 12463592
[TBL] [Abstract][Full Text] [Related]
18. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.
Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR
Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113
[TBL] [Abstract][Full Text] [Related]
19. Prophylaxis of graft-versus-host disease by lentiviral-mediated expression of herpes simplex virus-thymidine kinase and ganciclovir treatment.
Xu K; Zhu F; Du B; Gao F; Cheng H; Pan X
Transplant Proc; 2008 Oct; 40(8):2665-9. PubMed ID: 18929831
[TBL] [Abstract][Full Text] [Related]
20. Ganciclovir-sensitive acute graft-versus-host disease in mice receiving herpes simplex virus-thymidine kinase-expressing donor T cells in a bone marrow transplantation setting.
Contassot E; Ferrand C; Angonin R; Cohen JL; de Carvalho Bittencourt M; Lorchel F; Laithier V; Cahn JY; Klatzmann D; Herve P; Tiberghien P
Transplantation; 2000 Feb; 69(4):503-8. PubMed ID: 10708102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
